PGR and neoplasm: Factors associated with poor clinical outcomes or shorter survival in breast cancer include tumor size, tumor grade, axillary lymph node status, estrogen receptor (ER) status, progesterone receptor (PR) status, and human epidermal growth factor receptor 2 (Her2/neu) status [5, 6].